nad has been researched along with Hypertrophy, Right Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanif, K; Kaur, G; Lingeshwar, P; Siddiqui, HH; Singh, N | 1 |
| de Vries, HJ; Niessen, HW; Rodenburg, RJ; Stienen, GJ; Wintjes, LT; Wüst, RC | 1 |
2 other study(ies) available for nad and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Poly (ADP-ribose) polymerase-1: an emerging target in right ventricle dysfunction associated with pulmonary hypertension.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; In Situ Nick-End Labeling; Isoquinolines; Male; Mitochondria; Mitochondrial Membranes; Monocrotaline; NAD; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-2; Ventricular Dysfunction, Right | 2015 |
Mitochondrial complex I dysfunction and altered NAD(P)H kinetics in rat myocardium in cardiac right ventricular hypertrophy and failure.
Topics: Animals; Cardiomegaly; Disease Models, Animal; Heart; Hypertrophy, Right Ventricular; Male; Mitochondria; Myocardium; NAD; NADP; Oxygen Consumption; Rats, Wistar | 2016 |